Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

AZD3427 Effects on Renal Perfusion in Heart Failure Patients With Reduced Ejection Fraction and Renal Impairment

← catalyst calendar

NCT06611423

Sponsored by AstraZeneca (industry) · AZN — their whole pipeline →. With CTC Clinical Trial Consultants AB, Karolinska Institutet.

Phase
Phase 1
Status
Terminated
Study type
Interventional
Design
Randomized · Double · Treatment
Enrollment
10actual
Sites
1
Country
Sweden

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Why the sponsor stopped it

The Sponsor encountered difficulties in recruiting patients for clinical trial D8330C00004 and decided to end the study earlier for business reasons not affecting the benefit-risk balance.

As filed on the registry record, in the sponsor's own words.

Dates

each axis at the precision it was filed, with the registry's own basis
DateFiledBasisWhat it is
Start2024-10-15actualWhen the study began enrolling
Primary completion2025-08-21actualThe date the last participant is measured for the primary outcome — the readout window
Study completion2025-08-21actualThe whole study's end, after follow-up
First posted2024-09-25actualWhen this record first appeared on the registry
Results postedWhen the sponsor posted results to the registry
Record updated2025-09-24actualThe sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Conditions

  • Heart Failure With Reduced Ejection Fraction (HFrEF)
  • Renal Impairment

Interventions

  • Biological: AZD3427
  • Other: AZD3427 Placebo
  • Drug: Dopamine
  • Other: Radiolabelled ligand
  • Other: Saline

Primary outcome

what the primary-completion date above is the date OF
The volumetric fraction (%) of the renal cortex with increased perfusion from baseline to Day 8, compared to placebo.
measured Baseline to Day 8

Permalink · AZN's whole pipeline · Catalyst calendar · Every registered study · What changed